Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.8600
+0.0100 (1.18%)
At close: Aug 13, 2025, 4:00 PM
0.9033
+0.0833 (10.16%)
Pre-market: Aug 14, 2025, 4:16 AM EDT
Dyadic International Revenue
Dyadic International had revenue of $966.63K in the quarter ending June 30, 2025, with 150.49% growth. This brings the company's revenue in the last twelve months to $4.14M, up 129.20% year-over-year. In the year 2024, Dyadic International had annual revenue of $3.50M with 20.58% growth.
Revenue (ttm)
$4.14M
Revenue Growth
+129.20%
P/S Ratio
5.91
Revenue / Employee
$689,180
Employees
6
Market Cap
31.12M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.50M | 596.58K | 20.58% |
Dec 31, 2023 | 2.90M | -31.50K | -1.07% |
Dec 31, 2022 | 2.93M | 526.47K | 21.90% |
Dec 31, 2021 | 2.40M | 801.91K | 50.06% |
Dec 31, 2020 | 1.60M | -79.16K | -4.71% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
DYAI News
- 13 hours ago - Dyadic International, Inc. (DYAI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 17 hours ago - Dyadic Reports Second Quarter 2025 Financial Results and Highlights of Recent Company Progress - GlobeNewsWire
- 8 days ago - Dyadic to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025 - GlobeNewsWire
- 14 days ago - UPDATE: Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock - GlobeNewsWire
- 14 days ago - Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock - GlobeNewsWire
- 14 days ago - Dyadic International, Inc. Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 6 weeks ago - Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions - Business Wire
- 2 months ago - Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications - GlobeNewsWire